How have PTIXW shares performed in 2024?

Protagenic Therapeutics' stock was trading at $0.0150 at the beginning of 2024. Since then, PTIXW stock has increased by 49.8% and is now trading at $0.0225. View the best growth stocks for 2024 here .

How do I buy shares of Protagenic Therapeutics?

Shares of PTIXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PTIXW

Protagenic Therapeutics (PTIXW) Stock Price, News & Analysis

→ Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad)

Free PTIXW Stock Alerts

$0.02

0.00 (-13.46%)

(As of 04/25/2024 09:04 PM ET)

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.01
▼
$0.04
52-Week Range: $0.00
▼
$0.04

Volume: 700 shs
Average Volume: 4,683 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Social Media

Get Protagenic Therapeutics alerts:

Ad Colonial Metals

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

About Protagenic Therapeutics

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

PTIXW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PTIXW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive PTIXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:PTIXW
CUSIP: N/A
CIK: 1022899
Web: N/A
Phone: 212-994-8200
Fax: N/A
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Dr. Garo H. Armen Ph.D. (Age 71)
Co-Founder & Executive Chairman of the Board
Dr. Alexander Kenneth Arrow C.F.A. (Age 53)
M.D., CFO & Secretary
Comp: $150k
Dr. Andrew Slee Ph.D. (Age 74)
Chief Operating Officer
Dr. Robert Benjamin Stein M.D. (Age 73)
Ph.D., Chief Medical Officer & Director

Key Competitors

View All Competitors

PTIXW Stock Analysis - Frequently Asked Questions

How have PTIXW shares performed in 2024?: Protagenic Therapeutics' stock was trading at $0.0150 at the beginning of 2024. Since then, PTIXW stock has increased by 49.8% and is now trading at $0.0225.
View the best growth stocks for 2024 here.
How do I buy shares of Protagenic Therapeutics?: Shares of PTIXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PTIXW) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial